NEW YORK--(BUSINESS WIRE)--Regulatory News:
Philip Morris International Inc. (NYSE: PM) will host a live audio webcast on www.pmi.com/2021Q4earnings on Thursday, February 10, 2022, at 9:00 a.m. ET, to discuss its 2021 Fourth-Quarter and Full-Year results, which will be issued at approximately 7:00 a.m. ET the same day.
During the webcast, Emmanuel Babeau, Chief Financial Officer, will discuss PMI’s results, the outlook for 2022 and along with Jacek Olczak, Chief Executive Officer, answer questions from the investment community and news media. The webcast will be in a listen-only mode.
The audio webcast may also be accessed on iOS or Android devices by downloading PMI’s free Investor Relations Mobile Application on www.pmi.com/irapp.
An archived copy of the webcast will be available until 5:00 p.m. ET on Friday, March 11, 2022, on www.pmi.com/2021Q4earnings.
Slides and script will also be available on www.pmi.com/2021Q4earnings.
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company, its shareholders and other stakeholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smoke-free products, associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. In addition, versions of PMI's IQOS Platform 1 device and consumables have received marketing authorizations from the U.S. Food and Drug Administration (FDA) under the premarket tobacco product application (PMTA) pathway; the FDA has also authorized the marketing of a version of IQOS and its consumables as a Modified Risk Tobacco Product (MRTP), finding that an exposure modification order for these products is appropriate to promote the public health. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI's smoke-free product portfolio includes heat-not-burn products, nicotine-containing vapor products and oral nicotine products. As of September 30, 2021, PMI's smoke-free products are available for sale in 70 markets in key cities or nationwide, and PMI estimates that approximately 14.9 million adults around the world have already switched to IQOS and stopped smoking. For more information, please visit www.pmi.com and www.pmiscience.com.